понедельник, 3 июля 2017 г.

Indian pharma sector growth to moderate in next 3 years: ICRA

21 leading players' overall aggregate revenues grew only by 7.4 per cent in FY 2017 as against 10.1 per cent posted in FY 2016, the rating agency said.

Related Posts:

0 коммент.:

Отправить комментарий